Americans with a chronic disease could soon have better access to affordable treatment if a bipartisan bill just passed by the U.S. House makes it through ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Professor David Denning evaluates timely and accurate diagnosis of Aspergillus infection and the clinical spectrum of ...

When you hear the phrase "smoking kills"—which it does: nearly 500,000 Americans die from cigarette smoking each year—where ...

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised ads and content, ad and content measurement, audience ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

In today’s fast-paced world, respiratory health has become a significant concern for many. Conditions like asthma, Chronic ...

But now, scientists may have found a way to stop the condition in its tracks - and possibly even reduce the need for inhalers for day-to-day symptom management. A team at La Jolla Institute for ...

They may help to lower your risk of stroke. ACE inhibitors also are used to help control the progression of diabetes and kidney disease. Off-label uses outside of the drug's formal Food and Drug ...